Creabilis Therapeutics Appoints Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board

Published: Jul 29, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CANTERBURY, England, July 29, 2013 -- /PRNewswire/ -- Creabilis SA, a late stage European dermatology company with a focus on chronic pruritus (itch), today announces that it has appointed Professor Gil Yosipovitch and Professor Praveen Anand to its Scientific Advisory Board.

Help employers find you! Check out all the jobs and post your resume.

Back to news